OpSens is now part of

Enlightenment through smart measurements

Open menu

News & Events

OpSens Obtains CE Marking for the OptoWire III

18 February 2021

OpSens Obtains CE Marking for the OptoWire III   Quebec City, Quebec, February 18, 2021 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company commercializing a second-generation fiber optic pressure guidewire to diagnose and treat coronary disease, has announced it has received CE marking for the OptoWire III, the latest…

Read more

OpSens Solutions Fiber Optic Sensing Technology Selected for the International Thermonuclear Experimental Reactor (ITER)

8 February 2021

OpSens Solutions Fiber Optic Sensing Technology Selected for the International Thermonuclear Experimental Reactor (ITER) Quebec City, Quebec, February 8, 2021 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today announced that OpSens Solutions Inc. (“OpSens Solutions”), its wholly-owned subsidiary focused on applying the Company’s proprietary and innovative fiber optic measurement solutions to industrial applications,…

Read more

OpSens Announces $25 Million Bought Deal Offering

5 February 2021

OPSENS INC. ANNOUNCES $25 MILLION BOUGHT DEAL OFFERING   THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. Québec City, Canada, February 5, 2021 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) announced today that it…

Read more

OpSens Announces First Quarter fiscal 2021 financial Results

13 January 2021

OpSens Announces First Quarter fiscal 2021 financial Results Quebec City, Quebec, January 13, 2021 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company delivering diagnostic and treatment solutions based on its proprietary optical technology, today reported its financial results for the first quarter of fiscal 2021, ended November 30, 2020….

Read more

OpSens to Host First Quarter Fiscal Year 2021 Financial Results Conference Call on Wednesday, January 13, 2021

6 January 2021

OpSens to Host First Quarter Fiscal Year 2021 Financial Results Conference Call on Wednesday, January 13, 2021   Conference call to be conducted at 11:00 am ET Quebec City, Quebec, January 6, 2021 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company delivering diagnostic and treatment solutions based on its…

Read more

OpSens to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference

24 November 2020

OpSens to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference Quebec City, Quebec, November 24, 2020 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company delivering diagnostic and treatment solutions based on its proprietary optical technology, is presenting at the Piper Sandler 32nd Annual Virtual Healthcare Conference, and…

Read more

OpSens announces fourth quarter and fiscal year 2020 results

19 November 2020

OpSens Announces Fourth Quarter And Fiscal Year 2020 Financial Results Quebec City, Quebec, November 19, 2020 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today reported its results for the fourth quarter and fiscal year 2020 ended August 31, 2020. Financial Highlights Sales of product at $29.5 million in FY 2020 compared to prior…

Read more

OpSens recognized as one of the Fastest-Growing Companies in North America on Deloitte’s 2020 Technology Fast 500™

18 November 2020

OpSens recognized as one of the Fastest-Growing Companies in North America on Deloitte’s 2020 Technology Fast 500™ Quebec City, Quebec, November 18, 2020 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF),  a medical device cardiology-focused company commercializing a second-generation fiber optic pressure guidewire to diagnose and treat coronary disease, has been recognized in Deloitte’s…

Read more

OpSens to Present at the Virtual Fall Investor Summit On November 16

13 November 2020

Access OpSens’ presentation

OpSens to Host Year-End Update Conference Call on Thursday, November 19, 2020

12 November 2020

OpSens to Host Year-End Update Conference Call on Thursday, November 19, 2020 Conference call to be conducted on November 19, 2020 at 11:00 am ET Quebec City, Quebec, November 12, 2020 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company commercializing a  second generation fiber optic pressure guidewire to diagnose…

Read more